Express News | J&J - Currently Approved Intravenous Formulation of Rybrevant (Amivantamab-Vmjw) Is Not Impacted by Crl

Breakings05:05

Express News | J&J - FDA Issued Crl for Bla for Combination of Amivantamab & Recombinant Human Hyaluronidase for Subcutaneous Amivantamab

Breakings05:04

Dow's 111-Point Drop Led By Losses For UnitedHealth, Verizon Shares

MarketWatch04:52

Moderna Remains the Most Shorted Among S&P 500 Healthcare Stocks in November

Seeking Alpha02:05

Express News | J&J: Submits Application Seeking U.S. FDA Approval of Simponi® (Golimumab) for Treatment of Pediatric Ulcerative Colitis

BreakingsDec 16 20:49

Johnson & Johnson is suing a division of Cigna, accusing it of misappropriating a financial aid fund.

On December 16, Gleno Exchange reported that Johnson & Johnson has filed a lawsuit against a division of Cigna, accusing the medical insurance company of collaborating with pharmaceutical benefit managers to steal Johnson & Johnson's financial assistance funds, which are specifically designated for patients using some of Johnson & Johnson's high stock price drugs.

Gelonghui FinanceDec 16 14:46